# Associate Director, Global Medical Cardiovascular & Immunology, Medical Communications – Pulmonary Fibrosis — Bristol Myers Squibb

- Location: Princeton - NJ - US
- Posted pay: $156k–$188k/yr
- Posted: Nov 11, 2026
- Status: open (checked Nov 22, 2026)
- Apply (employer's site): https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Princeton---NJ---US/Associate-Director--Global-Medical-Cardiovascular---Immunology--Medical-Communications---Pulmonary-Fibrosis_R1608257
- Employer record: https://visajobs.io/company/bristol-myers-squibb.md

## Sponsorship history
- Tier: Good history
- Occupation (SOC): Medical Scientists, Except Epidemiologists (19-1042)
- …in the whole US: 103
- With this exact title: 0
- Median DOL prevailing wage, level I / II: $56k / $70k

## Description
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Position reports to the Director of Medical Communications within Global Medical Cardiovascular & Immunology, Global Medical Affairs and is responsible for leading the strategy and execution of publication plans for the pulmonary fibrosis (IPF/PPF) program. This role will ensure the disclosure and scientific content of the data and health economic value of BMS products and research data to inform Healthcare Providers, Patients, and Payers in accordance with local regulations.
Pulmonary fibrosis is at a pivotal moment, as new mechanisms enter a field that saw few new treatment options for more than a decade. The Associate Director will own the strategic rationale behind our publication, and to some extent scientific content, plans: assessing the scientific and competitive landscape, identifying evidence gaps, and determining where, when, and how BMS data are communicated to differentiate our program and build credibility with the interstitial lung disease (ILD) community. In practice, this means deciding which clinical trial results and analyses are published, in which peer-reviewed journals and at which medical conferences, and working with physician authors and agency partners to develop the manuscripts, abstracts, and presentations that communicate them.
This is an individual contributor role that leads through influence across cross-functional and matrix teams, combining strategic leadership with hands-on development of publications and scientific content alongside agency partners.
Key Responsibilities:
The Associate Director of Medical Communications is accountable for the following:
Medical Communications Strategy
Maintaining a deep, current understanding of the pertinent scientific and competitive landscape, including competitor data disclosures, publication patterns, congress/conference activity, and emerging evidence standards (e.g., endpoints, combination/background therapy data, patient-reported outcomes).
Conducting publication (and content) gap analyses and competitive publication audits to identify where BMS evidence can address unmet scientific needs and differentiate our program; translating findings into prioritized, evidence-based recommendations.
Developing and defending the strategic rationale for journal and congress/conference selection (audience, reach, timing, impact, competitive positioning) beyond defaulting to precedent.
Shaping and owning the pull-through of the Scientific Narrative and Communication Platform, ensuring publications and content tell a cohesive, differentiated story across the asset/medicine lifecycle and address communication needs across markets.
Translating strategy into a clear, viable, and functionally integrated publication and content plan, aligned with the therapeutic area (TA)-specific Medical Communications strategy and overall Medical vision and objectives.
Developing publications and scientific content (e.g., manuscripts, abstracts, congress/conference presentations, internal and external scientific materials) in partnership with authors and agencies, ensuring scientific accuracy, quality, and timely delivery.
Data Dissemination
Serving as a subject matter expert to BMS internal audiences related to communication landscape, HCP preferences, publication and scientific content planning, data disclosure / dissemination, and representing BMS scientific communications to external investigators, key authors and journal editors.
Leading internal process improvements to ensure BMS remains an ethical and credible leader in the practice of publications & scientific content; leading transformation efforts and ensuring BMS publication & scientific content standards are aligned with Good Publication Practices and industry standards, and all BMS employees engaged in publication activities follow Good Publication Practices guidance with the highest degree of integrity, quality and transparency.
Leading cross-functional publication teams in the development and execution of functionally integrated and aligned medical communications plans; adjusting communications plans in accordance with clinical trial results/milestones and changes in the healthcare landscape.
Demonstrating scientific/research expertise to support the establishment of strong working collaborations with both internal and external disease-area experts to ensure quality data analysis, interpretation, communication planning & data disclosure/dissemination.
Ensuring collection of insights to deliver high-quality medical communication that enables the most impactful dialogue and interactions with customers.
Identifying and driving opportunities to enhance processes, tools, operating procedures, and outsourcing strategy to ensure consistent delivery and alignment of standards
Stakeholder Engagement
Fostering collaborative relationships with academic & clinical experts, publishers, medical associations & other relevant key stakeholder groups; participating in external initiatives to foster trust and respect amongst academic and medical publishing community.
Collaborating with internal stakeholders across the Medical matrix (e.g., the country and regional medical directors) and other Scientific Communications & Engagement team (e.g., Customer Engagement, Field Medical Excellence, Congress Strategy, Training & Compliance) to leverage external insights to inform medical communications planning
Partnering with agencies and third-party vendors on executio

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
